Rosetta Genomics Ltd. (NASDAQ:ROSG): Despite recently published studies that miRview mets2 are able to identify 42 tumor types with high accuracy, Rosetta Genomics continues its volatile path. Shares fell 11.75% to close at $12.32, and they have traded in a 52-week range of $1.40 to $36.45.
Complete Genomics, Inc. (NASDAQ:GNOM): After a downgrade from Outperform to Market Perform by William Blair, Complete Genomics saw a 11.88% drop to close at $2.30. They have traded in a 52-week range of $1.57 to $18.55.
magicJack VocalTec Ltd (NASDAQ:CALL): It looks like MagicJack VocalTec wishes the Wall Street Journal weren’t so vocal. After a WSJ column took a critical look at the company’s strategy of financing stock buybacks by selling options, magicJack VocalTec shares dropped 9.93% to close at $13.78. They have traded in a 52-week range of $9.49 to $28.22.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.